Abound Wealth Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.1K Sell
93
-16
-15% -$4.21K 0.01% 328
2026
Q1
$29.1K Buy
109
+1
+0.9% +$271 0.01% 330
2025
Q4
$27.1K Sell
108
-32
-23% -$8.5K 0.01% 312
2025
Q3
$40.2K Buy
140
+63
+82% +$16.9K 0.01% 240
2025
Q2
$20.2K Hold
77
0.01% 329
2025
Q1
$17.8K Sell
77
-13
-14% -$3.15K 0.01% 315
2024
Q4
$20.5K Sell
90
-5
-5% -$1.15K 0.01% 277
2024
Q3
$21.3K Buy
95
+6
+7% +$1.32K 0.01% 280
2024
Q2
$18.1K Sell
89
-12
-12% -$2.44K 0.01% 267
2024
Q1
$22K Buy
101
+13
+15% +$2.86K 0.01% 230
2023
Q4
$20K Buy
88
+61
+226% +$12.8K 0.01% 261
2023
Q3
$5.44K Sell
27
-13
-33% -$2.74K ﹤0.01% 444
2023
Q2
$8.21K Buy
40
+11
+38% +$2.13K ﹤0.01% 380
2023
Q1
$5.74K Buy
29
+10
+53% +$2.06K ﹤0.01% 374
2022
Q4
$3.77K Buy
19
+13
+217% +$2.54K ﹤0.01% 403
2022
Q3
$1.03K Buy
+6
New +$1.23K ﹤0.01% 605

Other funds holding LH

Abound Wealth Management's LH Position: Q2 2026 in Review

Abound Wealth Management reduced its Labcorp (LH) stake by 15% in Q2 2026, selling an estimated $4.21K and leaving 93 shares worth $26.1K. The position accounts for 0.01% of the portfolio, ranked #328.

Abound Wealth Management first reported a position in LH in Q3 2022 and has held it in 16 quarters since. The position peaked at $40.2K in Q3 2025. 287 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Abound Wealth Management held 93 shares of Labcorp worth $26.1K as of Q2 2026.
  • Abound Wealth Management sold 16 Labcorp shares in Q2 2026, an estimated $4.21K.
  • Labcorp made up 0.01% of Abound Wealth Management's portfolio in Q2 2026, its #328 holding.
  • Abound Wealth Management first reported a position in Labcorp in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's Labcorp position peaked at $40.2K in Q3 2025.
  • 287 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.